Search research articles
Contact Us
Filters
Showing results (1-10 of 3,616) with videos related to
Page
of 362
Sort By:
Diabetes Technology & Therapeutics
|
December 8, 2022
A Longitudinal View of Disparities in Insulin Pump Use Among Youth with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
Estelle M Everett, Davene Wright, Adrienne Williams, et al.
Diabetes Technology & Therapeutics
|
June 28, 2022
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Gregory P Forlenza, Anders L Carlson, Rodolfo J Galindo, et al.
Diabetes Technology & Therapeutics
|
June 28, 2022
WITHDRAWN: Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
Laurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Diabetes Technology & Therapeutics
|
March 28, 2020
Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents
Erin C Cobry, Emily Hamburger, Sarah S Jaser
Diabetes Technology & Therapeutics
|
January 31, 2020
Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes
David Herzig, Joachim Dehais, Jean-Christophe Prost, et al.
Diabetes Technology & Therapeutics
|
February 28, 2020
Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
Jenna Sopfe, Tim Vigers, Laura Pyle, et al.
Diabetes Technology & Therapeutics
|
March 4, 2020
Precision Dosing of Rapid-Acting Insulin Matters
Henk-Jan Aanstoot, Henry Rodriguez, Stuart Weinzimer, et al.
Diabetes Technology & Therapeutics
|
July 16, 2021
Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System
Bruce Bode, Anders Carlson, Rong Liu, et al.
Diabetes Technology & Therapeutics
|
July 16, 2021
ONBOARD: A Feasibility Study of a Telehealth-Based Continuous Glucose Monitoring Adoption Intervention for Adults with Type 1 Diabetes
Molly L Tanenbaum, Jessica Ngo, Sarah J Hanes, et al.
Diabetes Technology & Therapeutics
|
July 12, 2021
Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 Diabetes
Thomas R Pieber, Olubukola Ajala, Oren Steen, et al.
Page
of 362
Search research articles
Search
Showing results (1-10 of 3,616) with videos related to
Sort By:
Page
of 362
Diabetes Technology & Therapeutics
|
December 8, 2022
A Longitudinal View of Disparities in Insulin Pump Use Among Youth with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study
Estelle M Everett, Davene Wright, Adrienne Williams, et al.
Diabetes Technology & Therapeutics
|
June 28, 2022
Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Gregory P Forlenza, Anders L Carlson, Rodolfo J Galindo, et al.
Diabetes Technology & Therapeutics
|
June 28, 2022
WITHDRAWN: Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
Laurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Diabetes Technology & Therapeutics
|
March 28, 2020
Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents
Erin C Cobry, Emily Hamburger, Sarah S Jaser
Diabetes Technology & Therapeutics
|
January 31, 2020
Pharmacokinetics of Faster and Standard Insulin Aspart During Fully Closed-Loop Insulin Delivery in Type 2 Diabetes
David Herzig, Joachim Dehais, Jean-Christophe Prost, et al.
Diabetes Technology & Therapeutics
|
February 28, 2020
Safety and Accuracy of Factory-Calibrated Continuous Glucose Monitoring in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
Jenna Sopfe, Tim Vigers, Laura Pyle, et al.
Diabetes Technology & Therapeutics
|
March 4, 2020
Precision Dosing of Rapid-Acting Insulin Matters
Henk-Jan Aanstoot, Henry Rodriguez, Stuart Weinzimer, et al.
Diabetes Technology & Therapeutics
|
July 16, 2021
Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System
Bruce Bode, Anders Carlson, Rong Liu, et al.
Diabetes Technology & Therapeutics
|
July 16, 2021
ONBOARD: A Feasibility Study of a Telehealth-Based Continuous Glucose Monitoring Adoption Intervention for Adults with Type 1 Diabetes
Molly L Tanenbaum, Jessica Ngo, Sarah J Hanes, et al.
Diabetes Technology & Therapeutics
|
July 12, 2021
Immunogenicity of the Novel Glucagon Analogue Dasiglucagon: Results of a Dedicated Immunogenicity Trial in Type 1 Diabetes
Thomas R Pieber, Olubukola Ajala, Oren Steen, et al.
Page
of 362